SEC Form 4 · accession 0000899243-19-001905
Intellia Therapeutics, Inc. · NTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 24, 2019 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001652130
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.78 | Jan 23, 2019 | A | 38,000 | A | — | Jan 22, 2029 | Common Stock | 38,000 | 38,000 | D |
Explanation of responses
- F1This option was granted on January 23, 2019 with respect to 38,000 shares of Common Stock, with 33% vesting on January 23, 2020 and the remaining 67% vesting in eight substantially equal quarterly installments thereafter.